Roche’s Genentech is ending a partnership with Nykode Therapeutics that centered around a clinical-stage cancer vaccine ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

It also comes after a pledge by the company to plough savings from a cost-reduction drive back into its pipeline. The three platform deals are long-term bets, but broaden Genentech’s drug ...

Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and ...

and is coming up to a two-decade anniversary at the Roche/Genentech group. She also took control of the company during Hardy’s recent sabbatical, a longstanding policy at the biotech unit that ...

Key regulatory milestones and financial updates position Sangamo Therapeutics Inc (SGMO) for potential growth despite funding ...

Travel Burden and Travel Costs of Bispecific Antibodies in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Relapsed/Refractory Follicular Lymphoma #782 oral presentation ...

Jasper Therapeutics, a biotech looking to make stem cell transplants less taxing and to treat immune-mediated diseases, reported on Monday that its experimental drug helped patients with a chronic ...

Sangamo Therapeutics, a genomic medicine company, focuses on developing treatments for serious ... of a Fabry disease treatment and promising collaborative efforts with Genentech and Pfizer. Key ...

“Onco360 is grateful for the opportunity to partner with the team at Genentech and become a specialty pharmacy provider for Itovebi ™ ,” said Benito Fernandez. “We are proud to add another treatment ...

Nov. 13, 2024 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and Valo Health today announced ... and Head of Boston Roche Innovation Center (BRIC), for Roche/Genentech and ...